Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Cancer Management and Research
|
March 14, 2022
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy
Massimiliano Salati, Luigi Marcheselli, Carlo Messina, et al.
Clinics and Research in Hepatology and Gastroenterology
|
May 24, 2022
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study
Francesco Caputo, Fabio Gelsomino, Andrea Spallanzani, et al.
Cancer Management and Research
|
June 14, 2019
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study
Andrea Casadei-Gardini, Emanuela Scarpi, Paola Ulivi, et al.
Frontiers in Digital Health
|
April 27, 2026
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center
Luca Moscetti, Enrico Calanchi, Elisa Pettorelli, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 14, 2024
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants
Catia Carconi, Carlo Bosi, Mario Scartozzi, et al.
American Journal of Cancer Research
|
October 18, 2021
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma
Massimiliano Dall'Ora, Giulia Rovesti, Luca Reggiani Bonetti, et al.
Cancers
|
April 25, 2020
The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled Analysis
Fabio Gelsomino, Andrea Casadei-Gardini, Daniele Rossini, et al.
The Oncologist
|
March 13, 2020
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
Nicole Brighi, Francesco Panzuto, Roberta Modica, et al.
Journal of Clinical Medicine
|
April 30, 2021
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center
Margherita Rimini, Annarita Pecchi, Francesco Prampolini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Massimiliano Salati, Francesco Caputo, David Cunningham, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Cancer Management and Research
|
March 14, 2022
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy
Massimiliano Salati, Luigi Marcheselli, Carlo Messina, et al.
Clinics and Research in Hepatology and Gastroenterology
|
May 24, 2022
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study
Francesco Caputo, Fabio Gelsomino, Andrea Spallanzani, et al.
Cancer Management and Research
|
June 14, 2019
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study
Andrea Casadei-Gardini, Emanuela Scarpi, Paola Ulivi, et al.
Frontiers in Digital Health
|
April 27, 2026
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center
Luca Moscetti, Enrico Calanchi, Elisa Pettorelli, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 14, 2024
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants
Catia Carconi, Carlo Bosi, Mario Scartozzi, et al.
American Journal of Cancer Research
|
October 18, 2021
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma
Massimiliano Dall'Ora, Giulia Rovesti, Luca Reggiani Bonetti, et al.
Cancers
|
April 25, 2020
The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled Analysis
Fabio Gelsomino, Andrea Casadei-Gardini, Daniele Rossini, et al.
The Oncologist
|
March 13, 2020
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
Nicole Brighi, Francesco Panzuto, Roberta Modica, et al.
Journal of Clinical Medicine
|
April 30, 2021
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center
Margherita Rimini, Annarita Pecchi, Francesco Prampolini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Massimiliano Salati, Francesco Caputo, David Cunningham, et al.
Page
of 8